Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kisvarda – page 15

175 clinical trials in Kisvarda, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kisvarda at a glance
175
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

175 trials in Kisvarda

Open in trial search

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Colitis ulcerative

Not recruiting

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen - Cilag International

Crohn's disease

Not recruiting

Study on Ustekinumab for Children with Moderate to Severe Crohn's Disease

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen - Cilag International

Cardiovascular disorder+1

Not recruiting

Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:LY3437943 sodium
  • Sponsor:Eli Lilly & Co.

Cardiac failure+4

Not recruiting

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:CDR132L
  • Sponsor:Cardior Pharmaceuticals GmbH

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Kisvarda

What the registry says about research in the country

01 Stroke Prevention & Treatment

Groundbreaking research focusing on ischemic stroke prevention and treatment, evaluating novel therapeutic approaches including oral inhibitors and specialized compounds.

  • Post-stroke Prevention
  • Transient Ischemic Attack Management
  • Blood Clot Prevention

Multiple studies are exploring innovative medications to reduce stroke recurrence risk in high-risk patients.

02 Neurological Imaging

Advanced research in contrast enhancement agents for magnetic resonance imaging, specifically targeting central nervous system pathology assessment.

  • Brain Imaging Advancement
  • Spinal Cord Diagnostics
  • MRI Enhancement Technology

Studies focus on developing safer and more effective contrast agents for neurological diagnosis.

03 Respiratory Medicine

Critical research into treatment options for Acute Respiratory Distress Syndrome, particularly cases resulting from pneumonia and other infections.

  • ARDS Treatment
  • Pneumonia Complications
  • Respiratory Care Innovation

Investigating novel protein-based therapies to improve patient outcomes in severe respiratory conditions.

04 Neuromuscular Disorders

Innovative treatments for lower limb spasticity, particularly focusing on post-stroke and traumatic brain injury complications.

  • Spasticity Management
  • Mobility Enhancement
  • Therapeutic Interventions

Clinical evaluation of specialized toxin treatments for improved muscle control and functionality.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.